Evaluation of the Efficacy of Topical Ophthalmic Steroids in a Modified Conjunctival Allergen Challenge (CAC) Model

NCT01534195 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Prednisolone Sodium Phosphate Ophthalmic Solution 1%
DRUG: Tears Naturale II Ophthalmic Solution

Sponsor

ORA, Inc.